Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-030302

President and CEO sold 14,806 shares at $5.04 ($74,548)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Touchon Pascal President and CEO 2022-08-16 Sale −14,806 $5.04 $74,548 457,287 D
Open-market sales · 14,806 sh · avg $5.04 · $74,548
Loading xslF345X03/form4.xml…